1 paper1 finding
Digital breast tomosynthesis plus synthesised two-dimensional mammography
downin humans1OR 0.71
Digital breast tomosynthesis plus synthesised two-dimensional mammography lowers the risk of invasive interval breast cancer incidence in humans (4.5 versus 6.3 cases per 10,000 screen-negative women; OR 0.71 (95% CI 0.52–0.97)).
“6·3 cases per 10 000 women screened with a negative result; OR 0·71 [95% CI 0·52-0·97]).”
Human trialScreen-negative women; compared with digital mammographybreast12 monthsfemales
3D breast screening may reduce cancers between scans
The Lancet. Oncology9 Oct 2026
More on Digital breast tomosynthesis plus synthesised two-dimensional mammography
Over 24 months after a negative screen, invasive cancer rates were 14.2 per 10,000 women with 3D screening versus 18.6 with standard mammography.Over 24 months after a negative screen, invasive cancer rates were 14.2 per 10,000 women with 3D screening versus 18.6 with standard mammography.